Originally published byEU-Startups
Imperagen, a Manchester-based BioTech company using AI and quantum physics to engineer better enzymes faster, has closed €5.7 million (£5 million) in Seed funding to accelerate R&D, expand its wet lab capabilities, and build out its go-to-market function over the next 18 months. The round was led by PXN Ventures with participation from Imperagen’s existing […]
The post Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Microsoft storms RAMPART, adds Clarity to agentic AI safety
12h ago
AI code accelerates production failures and spending, study finds
1d ago
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
Earlybird raising €500m defence fund with French investor AVP, sources say
5h ago